EVALUATION OF ANTERIOR CHAMBER INFLAMMATORY ACTIVITY IN EYES TREATED WITH INTRAVITREAL BEVACIZUMAB

Abstract

No inflammatory response was detected clinically and by the laser flare meter after intravitreal bevacizumab administration. The slight reduction in anterior chamber flare could be due to the known antiinflammatory effect of anti-vascular endothelial growth factor therapy.